Hepatitis B virus core protein with hot-spot mutations inhibit MxA gene transcription but has no effect on inhibition of virus replication by interferon α

Virology Journal

Volumn 7, Issue , 2010, Pages

  Zhijian, Yu ^a   Zhen, Huang ^a   Fan, Zhang ^b   Jin, Yang ^a   Qiwen, Deng ^a   Zhongming, Zeng ^a  

^a Shenzhen Nanshan People s Hospital and the 6th Affiliated Hospital of Shenzhen University Medical School   (China)

^b GUANGDONG MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CORE PROTEIN; HEPATITIS B VIRUS CORE PROTEIN; UNCLASSIFIED DRUG; VIRUS DNA; GUANINE NUCLEOTIDE BINDING PROTEIN; HEPATITIS B CORE ANTIGEN; MYXOVIRUS RESISTANCE PROTEINS;

ARTICLE; CONTROLLED STUDY; DOWN REGULATION; GENETIC TRANSCRIPTION; HEPATITIS B VIRUS; MXA GENE; NONHUMAN; PLASMID; VIRUS GENE; VIRUS INHIBITION; VIRUS REPLICATION; CELL LINE; DRUG ANTAGONISM; GENE EXPRESSION PROFILING; GENETICS; HUMAN; IMMUNOLOGY; LIVER CELL; METABOLISM; MISSENSE MUTATION; PHYSIOLOGY; VIROLOGY;

HEPATITIS B VIRUS;

CELL LINE; GENE EXPRESSION PROFILING; GTP-BINDING PROTEINS; HEPATITIS B CORE ANTIGENS; HEPATITIS B VIRUS; HEPATOCYTES; HUMANS; INTERFERON-ALPHA; MUTATION, MISSENSE; TRANSCRIPTION, GENETIC; VIRUS REPLICATION;

EID: 77957998606     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-7-278     Document Type: Article

References (25)

1. The role of mutations in core protein of hepatitis B virus in liver fibrosis. A Mohamadkhani FR Jazii H Poustchi O Nouraein S Abbasi M Sotoudeh G Montazeri, Virol J 2009 6 209 10.1186/1743-422X-6-209 19939285
2. Downregulation of HLA class II molecules by G1896A pre-core mutation in chronic hepatitis B virus infection. A Mohamadkhani M Sotoudeh S Bowden H Poustchi FR Jazii K Sayehmiri R Malekzadeh, Viral Immunol 2009 22 295 300 10.1089/vim.2009.0031 19811086
3. CTL escape mutations of core protein are more frequent in strains of HBeAg negative patients with low levels of HBV DNA. H Sendi M Mehrab-Mohseni S Shahraz H Norder SM Alavian B Noorinayer MR Zali P Pumpens HL Bonkovsky LO Magnius, J Clin Virol 2009 46 259 264 10.1016/j.jcv.2009.08.002 19748824
4. Hot-spot mutations in hepatitis B virus core gene: eliciting or evading immune clearance? Z Liu K Luo H He J Hou, Journ Viral Hepat 2005 12 146 153 10.1111/j.1365-2893.2005.00552.x (Pubitemid 40342172)
5. Study of the quasispecies dynamics of serum hepatitis B virus in a patient with acute exacerbations of chronic hepatitis B. L Liu YM Wang L Lan JG Li GH Deng J Xia XL Zhao XQ Zhang, Zhonghua Gan Zang Bing Za Zhi 2006 14 1 29 32 (in chinese with english abstract) 16420761
6. Phosphorylation of hepatitis B virus Cp at Ser87 facilitates core assembly. HY Kang S Lee SG Park J Yu Y Kim G Jung, Biochem J 2006 398 2 311 317 10.1042/BJ20060347 16740137
7. A frequent naturally occurring mutation (P130T) of human hepatitis B virus core antigen is compensatory for immature secretion phenotype of another frequent variant (I97L). TT Yuan C Shih, J Virol 2000 74 4929 4932 10.1128/JVI.74.10.4929-4932.2000 10775637
8. Replication advantage and host factor-independent phenotypes attributable to a common naturally occurring capsid mutation (I97L) in human hepatitis B virus. FM Suk MH Lin M Newman S Pan SH Chen JD Liu C Shih, J Virol 2002 76 12069 12077 10.1128/JVI.76.23.12069-12077.2002 12414948
9. Low level secretion of human hepatitis B virus caused by two independent, naturally occurring mutations (P5T and L60V) in the capsid protein. SL Pogam TT Yuan GK Sahu S Chatterjee C Shih, J Virol 2000 74 9099 9105 10.1128/JVI.74.19.9099-9105.2000 10982356
10. Identification of the hepatitis B virus factor that inhibits expression of the beta interferon gene. TM Whitten AT Quets RH Schloemer, J Virol 1991 65 4699 4704 1870197
11. Posttranscriptional regulation of hepatitis B virus replication by the precore protein. PP Scaglioni M Melegari JR Wands, J Virol 1997 71 345 353 8985356
12. Inhibition of interferon-inducible MxA protein expression by hepatitis B virus capsid protein. O Rosmorduc H Sirma P Soussan E Gordien P Lebon M Horisberger C Brechot D Kremsdorf, J Gen Virol 1999 80 1253 1262 10355772
13. Modulation of cell proliferation and differentiation of human lung carcinoma cells by the interferon-alpha. D Krejcov J Prochzkov L Kubala J Pacherník, Gen Physiol Biophys 2009 28 3 294 301 10.4149/gpb-2009-03-294 20037195
14. Interferon-induced Mx proteins in antiviral host defense. O Haller P Staeheli G Kochs, Biochimie 2007 89 812 818 10.1016/j.biochi.2007.04.015 17570575 (Pubitemid 47001645)
15. Mx proteins: mediators of innate resistance to RNA viruses. O Haller M Frese G Kochs, Rev Sci Tech 1998 17 220 230 9638812
16. GTPase activity is not essential for the interferon-inducible MxA protein to inhibit the replication of hepatitis B virus. ZJ Yu ZH Wang JJ Chen H Li ZZ Lin F Zhang YP Zhou J Hou, Arch Virol 2008 153 1677 1684 10.1007/s00705-008- 0168-9 18668195
17. Inhibition of hepatitis B virus replication by the interferon-inducible MxA protein. E Gordien O Rosmorduc C Peltekian F Garreau C Brechot D Kremsdorf, J Virol 2001 75 2684 2691 10.1128/JVI.75.6.2684-2691.2001 11222692
18. Hepatitis B virus downregulates the human interferon-inducible MxA promoter through direct interaction of precore/core proteins. M Fernndez JA Quiroga V Carrẽo, J Gen Virol 2003 84 8 2073 2082 10.1099/vir.0.18966-0 12867637
19. Signal peptide of Arabinosidase enhances secretion of interferon-alpha2b protein by Bifidobacteria longum. Q Deng W Zeng Z Yu, Arch Microbiol 2009 191 9 681 686 10.1007/s00203-009-0496-5 19652954
20. Upregulation of myxovirus-resistance protein A: a possible marker of type I interferon induction in systemic sclerosis. P Air C Ghidini C Zanotti M Scarsi R Cattaneo L Caimi L Imberti, J Rheumatol 2008 35 11 2192 2200 10.3899/jrheum.080418 18843779
21. Low pretreatment serum HBsAg level and viral mutations as predictors of response to PEG-interferon alpha-2b therapy in chronic hepatitis B. P Tangkijvanich P Komolmit V Mahachai P Sa-nguanmoo A Theamboonlers Y Poovorawan, J Clin Virol 2009 46 2 117 123 10.1016/j.jcv.2009.07.005 19651540
22. Hepatitis B virus particle formation in the absence of pregenomic RNA and reverse transcriptase. W Schormann A Kraft D Ponsel V Bruss, J Virol 2006 80 8 4187 4190 10.1128/JVI.80.8.4187-4190.2006 16571836
23. Human MxA protein participates to the interferon-related inhibition of hepatitis B virus replication in female transgenic mice. C Peltekian E Gordien F Garreau V Meas-Yedid P Soussan V Willams ML Chaix JC Olivo-Marin C Bréchot D Kremsdorf, J Hepatol 2005 43 6 965 972 10.1016/j.jhep.2005.06. 019 16168514
24. Antiviral Activity of Interferon- against Hepatitis B Virus Can Be Studied in Non-hepatic Cells and Is Independent of MxA. A Rang M Bruns T Heise H Will, J Biol chem 2002 277 7645 7647 10.1074/jbc.C100729200 11781305
25. Interferon-a inhibits hepatitis C virus subgenomic RNA replication by an MxA-independent pathway. M Frese T Pietschmann D Moradpour O Haller R Bartenschlager, J Gen Virol 2001 82 723 733 11257176